Trial Profile
Phase II Study: Evaluate Dose-Response of Iocide Oral Rinse in a Human Clinical Trial of Gingival Inflammation and Investigate Effects of Biological Markers Indicative of Systemic Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Iodine (Primary)
- Indications Gingivitis
- Focus Therapeutic Use
- Sponsors Biomedical Development Corporation
- 25 Feb 2016 New trial record
- 28 Jan 2013 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.